Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on stereoselective synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-catalyzed process for 1-beta-methyl carbapenem intermediates. High yield, mild conditions, scalable production for global supply chains.
Patent CN1525964A reveals a novel high-purity Biperiden synthesis route. Discover cost-effective manufacturing solutions for Parkinson's disease API intermediates with superior stereocontrol.
Advanced stereoselective synthesis of Phencyclonate optical isomers via Mandelic acid template. Superior purity and scalable route for pharmaceutical manufacturing.
Novel semi-synthesis of paclitaxel and docetaxel using trans-chiral side chains and stereochemical inversion. High yield, industrial scale potential.
Advanced stereoselective synthesis of Hyphantria cunea sex pheromones via CN101798293B. Delivers high enantiomeric excess and scalable agrochemical intermediate manufacturing.
Patent CN113754650A reveals a novel route for rosuvastatin calcium intermediates, drastically reducing cis-isomer impurities and enhancing pharmaceutical manufacturing efficiency.
Patent CN111393329A details a high-yield synthesis of BDH, a key ritonavir intermediate, utilizing stereoselective reduction for cost-effective manufacturing.
Patent CN112661802B reveals a scalable, non-toxic route for 3'-methoxyguanosine, offering significant cost reduction and supply chain reliability for mRNA cap analog manufacturing.
Discover a cost-effective synthesis of ganaxolone via direct methylation. Enhanced purity and supply chain reliability for pharmaceutical intermediates.
Patent CN1269795A reveals a scalable route for chiral alkoxyfuranone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel stereoselective route for tea geometrid sex pheromone using cheap diol. High yield, >98% ee, scalable for green pest control supply chains.
Patent CN113527388A details a novel DPPA-mediated method for beta-2-deoxy sugar synthesis, offering high stereoselectivity and mild conditions for API manufacturing.
Novel method replaces Claisen condensation for high-purity dioxane acetate intermediates. Significantly reduces production costs and improves scalability for global statin manufacturers.
Patent CN101805380B details a scalable acetylation method for nucleoside intermediates, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN101553477A reveals a novel route for L-gluconic acid production, offering cost reduction in API manufacturing through improved yields and shorter reaction times.
Patent CN111377986B details a novel purification method for decitabine intermediate II, removing critical impurities to enhance beta-configuration yield and supply reliability.
Advanced stereocontrolled synthesis of trans-5-chloro-2-methyl-dibenzo-oxepino-pyrrole intermediates. Enhancing yield and purity for global pharmaceutical supply chains.
Solve low-yield challenges in alpha-vinyl azide production. This patent-validated method offers 80%+ yield, broad substrate scope, and scalable manufacturing for pharma R&D and procurement teams.
Solve supply chain risks with air-stable, metal-free synthesis of trifluoroacetimide dihydrobenzofuran. High stereoselectivity, low cost, and scalable to 100MT/yr.
Solve supply chain risks with air-atmosphere, metal-free synthesis of trifluoroacetimide-substituted dihydrobenzofuran. High stereoselectivity, low-cost raw materials, and scalable to gram level for pharma R&D and production.